About 200 reports

  • Revenue Breakdown (%), by Business Segment, 2016
  • Revenue Breakdown (%), by Business Segment, 2016

The lab automation market for in-vitro diagnostics was valued at USD 949.1 million in 2017, and is expected to reach a value of USD 1230.9 million by 2023 at a CAGR of 4.31%, over the forecast period (2018-2023).The scope of the report is limited to products offered by major players for various purposes which include Automated Plate Handler,...

  • Diagnostics
  • North America
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton Property Group
  • Infectious Diagnostics Market, United States, Company Share (%) 2017
  • Infectious Diagnostics Market, United States, Company Share (%) 2017 .................................................... 123

United States Infectious Diagnostics Market Outlook to 2024 Summary GlobalData’s new report, United States Infectious Diagnostics Market Outlook to 2024, provides key market data on the United States Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units)...

  • Diagnostics
  • North America
  • Alere Inc.
  • bioMerieux S.A.
  • DiaSorin S.p.A.
  • INFECTIOUS DIAGNOSTICS MARKET, MEXICO, COMPANY SHARE (%) 2017
  • DILON DIAGNOSTICS ENTERS INTO DISTRIBUTION AGREEMENT WITH GE HEALTHCARE IN NORTH AMERICA

Mexico In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Summary GlobalData’s new report, Mexico In Vitro Diagnostics (IVD) Market Outlook to 2024, provides...

  • Diagnostics
  • North America
  • Forecast
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Molecular Diagnostics Market: Revenue in USD million, by In Situ Hybridization, North America,
  • Molecular Diagnostics Market: Revenue in USD million, by Application, South Africa, 2017-2022

Molecular Diagnostics Market The market was valued at USD 6 billion in 2015 and is expected to grow to USD 6.58 in 2016 and USD 9.53 billion by 2021, at a CAGR of 9.7%. Molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions,...

  • Diagnostics
  • North America
  • Market Size
  • Cepheid
  • Roche Group
  • In-vitro Diagnostics Market: Revenue in USD billion, POC Diagnostics, United States, 2018-2023
  • In-vitro Diagnostics Market: Revenue in USD billion, Tissue Diagnostics, United States, 2018-2023

The US in-vitro diagnostics market has been estimated at USD 13.57 billion in 2017 and is expected to register a CAGR of 5.57% during the forecast period, 2018 to 2023. Due to increasing incidences of chronic diseases and rapid adoption of point-of-care testing, along with increasing preference for personalized medicine, the in-vitro diagnostics...

  • Diagnostics
  • North America
  • Becton Property Group
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ROCHE DIAGNOSTICS REVENUE (2012Ͳ2015) ($ MILLIONS)
  • U.S. HEMATOLOGY DIAGNOSTICS MARKET (2015/2020) ($ MILLIONS)

United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S....

  • Diagnostics
  • North America
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Roche Group
  • United States - Forecast for Molecular Diagnostics Application Market Share (Percent), 2017 -
  • United States - Molecular Diagnostics Application Test Volume Share (Percent), 2010 - 201629

By 2024, United States molecular diagnostics market is expected to cross US$ 9 billion. Main factors pouring the growth of molecular diagnostics market are increased incidence of infectious diseases and different types of cancer. On the other hand, advancement of new technologies in the field of medicine and research fuels the molecular diagnostics...

  • Diagnostics
  • North America
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.
  • Business Segment: Tissue Diagnostics
  • Roche Diagnostics International Ltd - Weaknesses

Roche Diagnostics International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Diagnostics
  • In Vitro Diagnostics
  • North America
  • Market Segment
  • Roche Group

Tissue Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024 Section ## Preface ##. ## Report Scope and Market Segmentation ##. ## Research Highlights Section-## Assumptions and Research Methodology ##. ## Assumptions and Acronyms Used ##. ## Resea

  • Diagnostics
  • APAC
  • North America
  • World
  • Market Size

Hospital - Acquired Infection (HAI) Diagnostics Market - Global Market Size, Share, Development, Growth, and Demand Forecast, 2016 - 2023 Chapter ##.

  • Diagnostics
  • Health Services
  • Hospital
  • North America
  • Market Size

Global Animal Therapeutics and Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## Strategic Benchmarking ##. ## Opportuni

  • Diagnostics
  • Therapy
  • North America
  • Forecast
  • Market Size

Global Molecular Diagnostics Market (2016 - 2022) Table of Contents: Global Molecular Diagnostics Market Chapter ##.

  • Diagnostics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • North America
  • Market Size

Global Transfusion Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Application Analysis ##. ## Strategic Benchmarking ##. ## Opportunity Analy

  • Diagnostics
  • APAC
  • North America
  • Forecast
  • Market Size

Global DNA Diagnostics Market (2016-2022) Table of Contents Chapter ##.

  • Diagnostics
  • APAC
  • North America
  • World
  • Market Size
  • 6.7 Becton Dickinson - United States Molecular Diagnostic Sales and
  • ABBOTT LABORATORIES - UNITED STATES MOLECULAR DIAGNOSTIC SALES (MILLION US$), 2010 - 2014

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. The United States is the key market for molecular diagnostics...

  • Diagnostics
  • North America
  • Cepheid
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • MICROBIOME DIAGNOSTICS: DISTRIBUTION BY GEOGRAPHICAL LOCATION
  • Microbiome Therapeutics and Diagnostics Investments: Amount

INTRODUCTION Microbiome therapeutics represent a new frontier in the field of medicine. The human microbiome is characterized by more than 100 trillion commensal, symbiotic and pathogenic microorganisms that colonize the gut, mouth, skin and various other parts of the body. Majority of these microorganisms benefit humans by supplementing...

  • Diagnostics
  • Pharmaceutical
  • North America
  • Market Size
  • MicroBiome Therapeutics LLC
  • RECENT FINANCIALS (DIAGNOSTICS DIVISION)
  • F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2017)

Microfluidics market is projected to grow at a CAGR of 22.6% The microfluidics market is projected to reach USD 27.91 billion by 2023 from estimated USD 10.06 billion in 2018, at a CAGR of 22.6%. Quick returns on investment coupled with the fast results and improved portability of the medical equipment embedded with microfluidics...

  • Diagnostics
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • NON-INVASIVE CANCER DIAGNOSTICS MARKET (USD BILLION), 2017, 2023 AND 2030
  • NON-INVASIVE CANCER DIAGNOSTICS MARKET (2017-2030): BASE SCENARIO (USD BILLION)

INTRODUCTION Cancer is an extremely complex disease and medical science is still struggling to figure out the reasons and factors that influence the disease origin, propagation, spread (metastasis) and relapse. In 2017, a total of 1.7 million new cancer cases are estimated to be diagnosed in the US alone; during the same time...

  • Diagnostics
  • North America
  • Market Size
  • Biocept, Inc.
  • Transgenomic, Inc.
  • BUSINESS REVENUE MIX
  • RECENT FINANCIALS (Diagnostics Segment)

The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are some...

  • Diagnostics
  • North America
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • 7.4 SOFTWARE/INFORMATICS 7.4.1 DIAGNOSTICS
  • GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Diagnostics
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.

Expert Opinion on Medical Diagnostics; ##(##): ##-##.

  • Diagnostics
  • North America
  • Market Size
  • Alere Inc.
  • Roche Group
  • Net Sales (%), by Business Segment, 2017
  • Net Sales by Business Segment (%) - 2016

The global microfluidics market was valued at USD 4.552 billion in 2017, and is expected to reach USD 111.95 billion by 2023, recording a CAGR of 17.45% over the forecast period of 2018-2023. The scope of the report is limited to solutions offered by major players, including providers of microfluidic chips, micro pumps, and micro needles....

  • Diagnostics
  • Microfluidics
  • North America
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

North America Molecular Diagnostics Market (2016 - 2022) Table of Contents: North America Molecular Diagnostics Market Chapter ##.

  • Diagnostics
  • Molecular Diagnostic
  • North America
  • United States
  • Market Size

Strategic Initiatives List of Tables ##.

  • Diagnostic Imaging
  • Diagnostics
  • North America
  • United States
  • Market Size

North America DNA Diagnostics Market (2016-2022) Table of Contents Chapter ##.

  • Diagnostics
  • North America
  • Market Size
  • MICROBIOLOGY TESTING MARKET: REVENUE IN USD MILLION, BY LABORATORY INSTRUMENTS, CULTURE SYSTEMS,
  • MICROBIOLOGY TESTING MARKET: REVENUE IN USD MILLION, BY REAGENT, NORTH AMERICA, 2018-2023

Microbial cultures are one of the primary diagnostic methods used in microbiology.

  • Diagnostics
  • North America
  • Alere Inc.
  • bioMerieux S.A.
  • Cepheid

North America Molecular Diagnostics Market Analysis by Product, by Test Location, by Technology, by Application, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Segment Forecasts to 2024 Table of Content Chapter ## Executive Summary Chapter ## North A

  • Diagnostics
  • Molecular Diagnostic
  • North America
  • United States
  • Market Size
  • DIAGNOSTICS: AUTOMOTIVE SMART FLEET MANAGEMENT MARKET, BY REGION, 2015-2022, (USD BILLION)
  • THE ADAS SEGMENT IS EXPECTED TO LEAD THE MARINE SMART FLEET

“The focus on enhanced safety and reduced transportation cost to fuel the demand for smart fleet management market” The global smart fleet management market is projected to grow at a CAGR of 8.0% from 2017 to 2022, to reach USD 462.48 billion by 2022. The major factors responsible for the growth of the market include the introduction...

  • Diagnostics
  • North America
  • Forecast
  • Denso Corporation
  • Harman International Industries, Inc.
  • Revenue Breakdown (%), by Business Segment, 2017
  • Revenue Breakdown (%), by Business Segment, 2016

Lab-on-a chip and Microarrays Market The market was valued at USD 8.28 billion in 2012 and is projected to reach USD 33.32 billion by 2021, at a CAGR of 32.07% during the forecast period from 2016 to 2021. A biochip is a collection of miniaturized test sites (microarrays) that are arranged on a solid substrate, which permits many...

  • Diagnostics
  • North America
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • THERMO FISHER SCIENTIFIC, INC. (U.S.)
  • ACQUISITIONS, 2012-JANUARY 2017

Growing market for food diagnostics ##. ##. ##. ## Growing market for food diagnostics Food diagnostics provide an efficient method for detecting any contamination in the food sample.

  • Diagnostics
  • North America
  • Bureau Veritas SA
  • Intertek Group plc
  • SGS Canada Inc.